Deferred Income Tax Assets, Net in USD of CRYO CELL INTERNATIONAL INC from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
CRYO CELL INTERNATIONAL INC quarterly Deferred Income Tax Assets, Net history and change rate from Q4 2019 to Q3 2025.
  • CRYO CELL INTERNATIONAL INC Deferred Income Tax Assets, Net for the quarter ending 31 Aug 2025 was $20.8M, a 1.51% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

CRYO CELL INTERNATIONAL INC Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $20.8M +$309K +1.51% 31 Aug 2025 10-Q 15 Oct 2025
Q2 2025 $20.8M +$309K +1.51% 31 May 2025 10-Q 15 Jul 2025
Q1 2025 $20.8M +$309K +1.51% 28 Feb 2025 10-Q 14 Apr 2025
Q4 2024 $20.8M +$309K +1.51% 30 Nov 2024 10-Q 15 Oct 2025
Q3 2024 $20.5M +$6.75M +49.1% 31 Aug 2024 10-Q 15 Oct 2024
Q2 2024 $20.5M +$6.75M +49.1% 31 May 2024 10-Q 15 Jul 2024
Q1 2024 $20.5M +$6.75M +49.1% 29 Feb 2024 10-Q 15 Apr 2024
Q4 2023 $20.5M +$6.75M +49.1% 30 Nov 2023 10-K 28 Feb 2025
Q3 2023 $13.7M +$1.73M +14.4% 31 Aug 2023 10-Q 12 Oct 2023
Q2 2023 $13.7M +$1.73M +14.4% 31 May 2023 10-Q 14 Jul 2023
Q1 2023 $13.7M +$1.73M +14.4% 28 Feb 2023 10-Q 21 Apr 2023
Q4 2022 $13.7M +$1.73M +14.4% 30 Nov 2022 10-K 28 Feb 2024
Q3 2022 $12M +$1.65M +15.9% 31 Aug 2022 10-Q 18 Oct 2022
Q2 2022 $12M +$1.65M +15.9% 31 May 2022 10-Q 11 Jul 2022
Q1 2022 $12M +$1.65M +15.9% 28 Feb 2022 10-Q 13 Apr 2022
Q4 2021 $12M +$1.65M +15.9% 30 Nov 2021 10-K 28 Feb 2023
Q3 2021 $10.4M +$1.28M +14.1% 31 Aug 2021 10-Q 15 Oct 2021
Q2 2021 $10.4M +$1.28M +14.1% 31 May 2021 10-Q 15 Jul 2021
Q1 2021 $10.4M 28 Feb 2021 10-Q 14 Apr 2021
Q4 2020 $10.4M +$1.28M +14.1% 30 Nov 2020 10-K 22 Feb 2022
Q3 2020 $9.08M 31 Aug 2020 10-Q 15 Oct 2020
Q2 2020 $9.08M 31 May 2020 10-Q 10 Jul 2020
Q4 2019 $9.08M 30 Nov 2019 10-K 01 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.